These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6056920)

  • 21. [Results of a long-term anticoagulant therapy in patients with arteriosclerosis obliterans compared to a collective group with myocardial infarct].
    Schmidt HH; Heine H; Zimmermann B; Hackenberger F
    Z Gesamte Inn Med; 1971 Oct; 26(20):Suppl 20:275-7. PubMed ID: 5004145
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cardilan in the treatment of obliterative diseases of peripheral arteries].
    Ginko T; Adamczyk R; Dyaczyńska A
    Wiad Lek; 1971 Jun; 24(12):1211-5. PubMed ID: 5561279
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of long-term pentoxifylline treatment on selected parameters of the fibrinolytic system in patients with arteriosclerosis obliterans of the legs].
    Berent H; Kancelarczyk WL; Zebrowski M; Uchman B
    Pol Tyg Lek; 1988 Jun; 43(24):776-8. PubMed ID: 3237518
    [No Abstract]   [Full Text] [Related]  

  • 24. [Angiographic follow-up examination findings in arteriosclerosis obliterans with and without long-term anticoagulant therapy].
    Schmidt KH; Schmidt H; Heine H; Porstmann W; Driese H
    Dtsch Gesundheitsw; 1971 Feb; 26(8):346-9. PubMed ID: 4930644
    [No Abstract]   [Full Text] [Related]  

  • 25. [Direct long-term endolymphatic treatment of patients with arterial occlusive diseases of the lower extremities].
    Kungurtsev VV; Shimanko AI; Pishchita AN
    Klin Khir (1962); 1990; (7):49-51. PubMed ID: 2232539
    [No Abstract]   [Full Text] [Related]  

  • 26. [Intra-arterial heparin and vasodilator injections at the initial phase of acute arterial obliteration in the extremities].
    Bergogne C
    Rev Atheroscler (Paris); 1968; 10(2):11-3. PubMed ID: 4997999
    [No Abstract]   [Full Text] [Related]  

  • 27. [Combined treatment of aged patients with obliterative atherosclerosis of legs grade IV by intraarterial infusions and CO2-laser].
    Galimzianov FV; Belova AD
    Khirurgiia (Mosk); 1998; (12):18-21. PubMed ID: 9916427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of bencyclane in obliterative arterial diseases].
    Kusztos D
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1419+. PubMed ID: 5536658
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of rheopolyglucin in the treatment of obliterative atherosclerosis of the legs].
    Kokhan EP
    Klin Khir (1962); 1975 Nov; (11):65-6. PubMed ID: 1228283
    [No Abstract]   [Full Text] [Related]  

  • 30. [Fluvographic and oscillographic studies before and following intra-arterial injections of methylprednisolone and dihydro-derivatives of ergotoxin group in peripheral arterial blood circulation disorders].
    Knoth W; Schafé MK; Höland H
    Z Haut Geschlechtskr; 1966 Feb; 40(3):57-68. PubMed ID: 4963747
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of patients with occlusive arterial diseases of the legs with prostaglandin E1].
    Dibirov MD
    Vestn Khir Im I I Grek; 1988 Jun; 140(6):137-8. PubMed ID: 3222855
    [No Abstract]   [Full Text] [Related]  

  • 32. [Excretion of catecholamines in patients with obliterating arteriosis before and after complex conservative treatment].
    Mikeladze NA
    Klin Khir (1962); 1974 Jul; 7(0):21-5. PubMed ID: 4848703
    [No Abstract]   [Full Text] [Related]  

  • 33. [Intra-arterial administration of pyrrolidin-methyl-tetracycline in the treatment of various obliterative angiopathies].
    Del Corso P; Zeme D; Beverelli M
    Clin Ter; 1970 Nov; 55(3):231-8. PubMed ID: 5516887
    [No Abstract]   [Full Text] [Related]  

  • 34. [Medium term treatment with suloctidil in obliterating arteriopathies of the lower limbs. Personal experience].
    Marongiu G; Dettori G; Gadeddu A; Noya G; Angius P; Biglioli P
    Minerva Cardioangiol; 1983; 31(7-8):407-10. PubMed ID: 6316206
    [No Abstract]   [Full Text] [Related]  

  • 35. [Arterial diseases of the lower limbs. Treatment with anticoagulants. Value of their long-term use].
    Jouve A; Pierron J; Avril P; Nakache A
    Nouv Presse Med; 1972 Sep; 1(34):2250-2. PubMed ID: 4628245
    [No Abstract]   [Full Text] [Related]  

  • 36. [Coexistence of obliterative arteriosclerosis of the lower limb with coronary disease].
    Liszewska D; Lukasik E
    Kardiol Pol; 1968; 11(4):301-6. PubMed ID: 5709287
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of organic diseases of peripheral arteries with nicotinic acid derivatives].
    Liszewska D; Lukasik E
    Pol Tyg Lek; 1967 May; 22(21):794-6. PubMed ID: 6041002
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of etofibrate in the treatment of patients with hyperlipidemia and arteriosclerosis obliterans of the legs].
    Dembińska-Kieć A; Kostka-Trabka E; Grodzińska L; Bieroń K; Kedzior A; Basista M; Zmuda A; Trabka E; Sławiński M; Czarnecka B
    Pol Tyg Lek; 1987 Dec 21-28; 42(51-52):1643-8. PubMed ID: 3330798
    [No Abstract]   [Full Text] [Related]  

  • 39. [Arteriosclerosis: a challenge for the surgeon. Prevention and postoperative care (author's transl)].
    Rau G
    Langenbecks Arch Chir; 1975 Nov; 339():175-85. PubMed ID: 1207298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The use of vitamin B 15 in obliterative atherosclerosis of the lower lumbs].
    Afanas'eva LM
    Khirurgiia (Mosk); 1967 Dec; 43(12):36-8. PubMed ID: 5613253
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.